Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.45 - $46.68 $12.2 Million - $15.7 Million
-336,073 Reduced 98.03%
6,737 $314,000
Q1 2023

May 15, 2023

BUY
$39.51 - $61.95 $13.4 Million - $21 Million
338,571 Added 7987.05%
342,810 $15.3 Million
Q4 2022

Feb 14, 2023

SELL
$38.6 - $62.07 $96,808 - $155,671
-2,508 Reduced 37.17%
4,239 $246,000
Q3 2022

Nov 14, 2022

BUY
$42.86 - $77.02 $289,176 - $519,653
6,747 New
6,747 $289,000
Q2 2022

Aug 15, 2022

SELL
$64.69 - $85.07 $7.71 Million - $10.1 Million
-119,147 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$76.3 - $103.81 $9.09 Million - $12.4 Million
119,147 New
119,147 $9.88 Million
Q4 2021

Feb 14, 2022

SELL
$92.98 - $124.15 $15.3 Million - $20.4 Million
-164,700 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$77.49 - $109.17 $5.17 Million - $7.29 Million
-66,737 Reduced 28.84%
164,700 $16.9 Million
Q2 2021

Aug 16, 2021

BUY
$86.59 - $107.47 $20 Million - $24.9 Million
231,437 New
231,437 $22.1 Million
Q1 2021

May 17, 2021

SELL
$66.32 - $90.93 $889,152 - $1.22 Million
-13,407 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$46.7 - $75.22 $240,972 - $388,135
-5,160 Reduced 27.79%
13,407 $909,000
Q3 2020

Nov 16, 2020

BUY
$42.77 - $56.69 $794,110 - $1.05 Million
18,567 New
18,567 $859,000
Q2 2020

Aug 14, 2020

SELL
$26.54 - $44.24 $906,234 - $1.51 Million
-34,146 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$22.69 - $44.14 $632,733 - $1.23 Million
27,886 Added 445.46%
34,146 $1.04 Million
Q4 2019

Feb 14, 2020

BUY
$35.49 - $48.05 $222,167 - $300,793
6,260 New
6,260 $263,000
Q1 2018

May 15, 2018

SELL
$23.3 - $30.15 $282,768 - $365,900
-12,136 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$22.54 - $34.39 $273,545 - $417,357
12,136
12,136 $289,000

Others Institutions Holding AZTA

About Azenta, Inc.


  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.16B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.